General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sanofi(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), Takeda(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), Asahi(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: BRAVO4Health(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Amgen Inc.(SIGNIFICANT), Microbiome Technologies(NONE)

View Full Disclosure